XML 83 R69.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation - Restricted Stock Activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Dec. 31, 2016
Jun. 30, 2017
Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation expense recognized     $ 100 $ 100  
Number of Restricted Stock [Roll Forward]          
Shares Awarded, Exercised/Released (in shares)     (7,934)    
Shares Awarded, Cancelled/Forfeited (in shares)     (3,390)    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Weighted Average Grant Date Fair Value, Exercised/Released (in US$ per share)     $ 32.77    
Weighted Average Grant Date Fair Value, Cancelled/Forfeited (in US$ per share)     $ 25.57    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]          
Aggregate Intrinsic Value, Exercised/Released     $ 272    
Aggregate Intrinsic Value, Cancelled/Forfeited     $ 0    
Restricted Stock | Vested          
Number of Restricted Stock [Roll Forward]          
Shares Awarded, Ending balance (in shares) 17,231   17,231   15,445
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Weighted Average Grant Date Fair Value, Beginning balance (in US$ per share)     $ 29.79    
Weighted Average Grant Date Fair Value, Ending balance (in US$ per share) $ 32.35   $ 32.35   $ 29.79
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]          
Weighted Average Remaining Life, Beginning balance 1 year 7 months 6 days       11 months 12 days
Weighted Average Remaining Life, Ending balance 1 year 7 months 6 days       11 months 12 days
Aggregate Intrinsic Value, Beginning Balance     $ 467    
Aggregate Intrinsic Value, Ending Balance $ 554   $ 554   $ 467
Vested and Expected to Vest, Outstanding, Number (in shares) 16,411   16,411    
Vested and Expected to Vest, Weighted Average Exercise Price (in US$ per share) $ 32.32   $ 32.32    
Vested and Expected to Vest, Weighted Average Remaining Life 1 year 6 months 6 days        
Vested and Expected to Vest, Aggregate Intrinsic Value $ 528   $ 528    
2017 Plan [Member] | Restricted Stock          
Number of Restricted Stock [Roll Forward]          
Restricted stock granted (in shares)     13,110    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Restricted stock granted, weighted average grant date fair value (in US$ per share)     $ 33.88    
Share-based Compensation Arrangement by Share-based Payment Award, Equity instruments Other Than Options, Grants in Period, Weighted Average Remaining Contractual Term     1 year 8 months 12 days    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract]          
Aggregate Intrinsic Value, Granted     $ 444    
Omnibus Plan [Member] | Restricted Stock          
Number of Restricted Stock [Roll Forward]          
Restricted stock granted (in shares)       5,106  
Performance-Based Restricted Stock Units (PBRSUs)          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation expense recognized 0   0 $ 0  
Unrecognized compensation cost related to restricted stock 1,100 $ 0 1,100 $ 0  
Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Unrecognized compensation cost related to restricted stock 500   $ 500   $ 300
General and Administrative Expense | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]          
Compensation expense recognized $ 100 $ 100      
Director [Member]          
Number of Restricted Stock [Roll Forward]          
Restricted stock granted (in shares)     11,406    
Director [Member] | 2017 Plan [Member] | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Restricted stock granted, weighted average grant date fair value (in US$ per share)     $ 34.20    
Employee [Member]          
Number of Restricted Stock [Roll Forward]          
Restricted stock granted (in shares)     1,704    
Employee [Member] | 2017 Plan [Member] | Restricted Stock          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]          
Restricted stock granted, weighted average grant date fair value (in US$ per share)     $ 31.70